✨ Your Portfolio is fetched and updated from zerodha.
Micro Miscellaneous

Brawn Biotech Ltd.

BRAWN

Market Cap
₹6 Cr.
P/E
0.00

Brawn Biotech Ltd.

  • Brawn Biotech
  • Simplex Papers
  • Worldwide Aluminium
FAQs on Brawn Biotech Ltd. Shareprice

Brawn Biotech has given lower returns compared to its competitors.
Brawn Biotech has grown at ~0.96% over the last 10yrs while peers have grown at a median rate of 7.16%

Brawn Biotech is not expensive.
Latest PE of Brawn Biotech is 0.0, while 3 year average PE is 1.66.
Also latest EV/EBITDA of Brawn Biotech is 0.0 while 3yr average is 5.32.

View FAQ's On Business
Growth Table
  • Brawn Biotech Ltd.
  • Simplex Papers
  • Worldwide Aluminium
Balance Sheet
  • Brawn Biotech Ltd.
  • Simplex Papers
  • Worldwide Aluminium
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Brawn Biotech Ltd.
  • Simplex Papers
  • Worldwide Aluminium
Cash Flow
  • Brawn Biotech Ltd.
  • Simplex Papers
  • Worldwide Aluminium
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Brawn Biotech Ltd.
  • Simplex Papers
  • Worldwide Aluminium
Quarterly Results
  • Brawn Biotech Ltd.
  • Simplex Papers
  • Worldwide Aluminium
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Brawn Biotech Ltd. Financials

Balance sheet of Brawn Biotech is moderately strong.

Yes, The debt of Brawn Biotech is increasing.
Latest debt of Brawn Biotech is -₹0.24 Crs as of Sep-24.
This is greater than Mar-24 when it was -₹0.79 Crs.

No, profit is decreasing.
The profit of Brawn Biotech is -₹1.65 Crs for TTM, -₹1.24 Crs for Mar 2024 and -₹0.91 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Brawn Biotech latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech